GENE ONLINE|News &
Opinion
Blog

2021-04-16| SpecialTechnology

T Cells and Cancer: Uncovering the Unknowns

by Daniel Ojeda
Share To
T cells are potent cancer-killing immune cells but cancers have developed several ways to escape them. In recent years, immunotherapies such as CAR T cells and immune checkpoint inhibitors have reactivated the T cells to be effective against cancers. Understanding the interactions between cancer cells and T cells could help us develop novel therapeutics. Here we present key takeaways from the virtual AACR conference presentations that focussed on T Cells in Cancer.

GO Prime with only $1.49 now

LATEST
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlightll In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
Kite’s Yescarta Yields a Success in a Phase 3 Trial for Treating Large B-Cell Lymphoma
2023-03-22
Transcenta Announces First Patient Dosed in the U.S. Study of Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors
2023-03-22
Biogen’s Tofersen May Show Clinical Benefit in ALS Patients with Rare SOD1 Mutations
2023-03-21
Scroll to Top